A citation-based method for searching scientific literature

Joël Vos, Wilma Otten, Christi van Asperen, Anna Jansen, Fred Menko, Aad Tibben. Psychooncology 2008
Times Cited: 81







List of co-cited articles
453 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
29

Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Joël Vos, Encarna Gómez-García, Jan C Oosterwijk, Fred H Menko, Reinoud D Stoel, Christi J van Asperen, Anna M Jansen, Anne M Stiggelbout, Aad Tibben. Psychooncology 2012
48
39


Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
J O Culver, C D Brinkerhoff, J Clague, K Yang, K E Singh, S R Sand, J N Weitzel. Clin Genet 2013
57
31

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
548
18

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
Suzanne C O'Neill, Christine Rini, Rachel E Goldsmith, Heiddis Valdimarsdottir, Lawrence H Cohen, Marc D Schwartz. Psychooncology 2009
71
21


Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results.
J Vos, J C Oosterwijk, E Gómez-García, F H Menko, A M Jansen, R D Stoel, C J van Asperen, A Tibben, A M Stiggelbout. Clin Genet 2011
32
43


Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message.
Sandra van Dijk, Christi J van Asperen, Catharina E Jacobi, Geraldine R Vink, Aad Tibben, Martijn H Breuning, Wilma Otten. Genet Test 2004
32
34

Understanding of BRCA VUS genetic results by breast cancer specialists.
B K Eccles, E Copson, T Maishman, J E Abraham, D M Eccles. BMC Cancer 2015
55
20

Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review.
Phyllis N Butow, Elizabeth A Lobb, Bettina Meiser, Alexandra Barratt, Katherine M Tucker. Med J Aust 2003
123
12


A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.
Jodi T Heshka, Crystal Palleschi, Heather Howley, Brenda Wilson, Philip S Wells. Genet Med 2008
221
12

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
11

A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
Douglas F Easton, Amie M Deffenbaugh, Dmitry Pruss, Cynthia Frye, Richard J Wenstrup, Kristina Allen-Brady, Sean V Tavtigian, Alvaro N A Monteiro, Edwin S Iversen, Fergus J Couch,[...]. Am J Hum Genet 2007
312
11

What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer.
Sandra van Dijk, Wilma Otten, Daniëlle R M Timmermans, Christi J van Asperen, Hanne Meijers-Heijboer, Aad Tibben, Martijn H Breuning, Job Kievit. Genet Med 2005
42
21

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
11

No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result.
Michel Dorval, Geneviève Gauthier, Elizabeth Maunsell, Michel J Dugas, Isabelle Rouleau, Jocelyne Chiquette, Marie Plante, Rachel Laframboise, Michel Gaudet, Peter J Bridge,[...]. Cancer Epidemiol Biomarkers Prev 2005
39
23

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
Sandra van Dijk, Daniëlle R M Timmermans, Hanne Meijers-Heijboer, Aad Tibben, Christi J van Asperen, Wilma Otten. J Clin Oncol 2006
60
15

Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling.
S Richter, I Haroun, T C Graham, A Eisen, A Kiss, E Warner. Ann Oncol 2013
60
15

Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
Ilana Solomon, Elizabeth Harrington, Gillian Hooker, Lori Erby, Jennifer Axilbund, Heather Hampel, Kara Semotiuk, Amie Blanco, William M P Klein, Francis Giardiello,[...]. J Genet Couns 2017
28
32

Putting it all behind: long-term psychological impact of an inconclusive DNA test result for breast cancer.
Sandra van Dijk, Wilma Otten, Rob A E M Tollenaar, Christi J van Asperen, Aad Tibben. Genet Med 2008
13
61

Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives.
C Cypowyj, F Eisinger, L Huiart, H Sobol, M Morin, C Julian-Reynier. Psychooncology 2009
20
40

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
305
9


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
8

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Chanita Hughes Halbert, Tiffani DeMarco, William Lawrence, David Main, Clinton Finch, Colette Magnant,[...]. J Clin Oncol 2004
189
8

Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
235
8

Decision making with uncertain information: learning from women in a high risk breast cancer clinic.
Caren J Frost, Vickie Venne, Dianne Cunningham, Ruth Gerritsen-McKane. J Genet Couns 2004
32
21

A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report.
Robert Resta, Barbara Bowles Biesecker, Robin L Bennett, Sandra Blum, Susan Estabrooks Hahn, Michelle N Strecker, Janet L Williams. J Genet Couns 2006
365
8

Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results.
Suzanne C O'Neill, Tiffani DeMarco, Beth N Peshkin, Sarah Rogers, Jessica Rispoli, Karen Brown, Heiddis Valdimarsdottir, Marc D Schwartz. Am J Med Genet C Semin Med Genet 2006
49
14

A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).
Noralane M Lindor, Lucia Guidugli, Xianshu Wang, Maxime P Vallée, Alvaro N A Monteiro, Sean Tavtigian, David E Goldgar, Fergus J Couch. Hum Mutat 2012
140
8

BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.
Noralane M Lindor, David E Goldgar, Sean V Tavtigian, Sharon E Plon, Fergus J Couch. Oncologist 2013
58
12

A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes.
J M Eggington, K R Bowles, K Moyes, S Manley, L Esterling, S Sizemore, E Rosenthal, A Theisen, J Saam, C Arnell,[...]. Clin Genet 2014
116
8

BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
D M Eccles, G Mitchell, A N A Monteiro, R Schmutzler, F J Couch, A B Spurdle, E B Gómez-García. Ann Oncol 2015
110
8

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
129
8

Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
I van Oostrom, H Meijers-Heijboer, H J Duivenvoorden, A H J T Bröcker-Vriends, C J van Asperen, R H Sijmons, C Seynaeve, A R van Gool, J G M Klijn, A Tibben. Clin Genet 2007
55
10

Genetic evidence and integration of various data sources for classifying uncertain variants into a single model.
David E Goldgar, Douglas F Easton, Graham B Byrnes, Amanda B Spurdle, Edwin S Iversen, Marc S Greenblatt. Hum Mutat 2008
131
7

Unclassified variants in disease-causing genes: nonuniformity of genetic testing and counselling, a proposal for guidelines.
Geraldine R Vink, Christi J van Asperen, Peter Devilee, Martijn H Breuning, Egbert Bakker. Eur J Hum Genet 2005
22
27

No news is (not necessarily) good news: impact of preliminary results for BRCA1 mutation searches.
Alison Bish, Stephen Sutton, Christine Jacobs, Sara Levene, Amanda Ramirez, Shirley Hodgson. Genet Med 2002
30
20

What do women really want to know? Motives for attending familial breast cancer clinics.
C J Van Asperen, S Van Dijk, M W Zoeteweij, D R M Timmermans, G H De Bock, E J Meijers-Heijboer, M F Niermeijer, M H Breuning, J Kievit, W Otten. J Med Genet 2002
54
11

A systematic review of the impact of genetic counseling on risk perception accuracy.
Chris M R Smerecnik, Ilse Mesters, Eline Verweij, Nanne K de Vries, Hein de Vries. J Genet Couns 2009
83
7

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
7



A counselee-oriented perspective on risk communication in genetic counseling: explaining the inaccuracy of the counselees' risk perception shortly after BRCA1/2 test result disclosure.
Joël Vos, Anne M Stiggelbout, Jan Oosterwijk, Encarna Gomez-Garcia, Fred Menko, J Margriet Collee, Christi J van Asperen, Aad Tibben. Genet Med 2011
15
40

Errors in delivery of cancer genetics services: implications for practice.
Karina L Brierley, Danielle Campfield, Whitney Ducaine, Lindsay Dohany, Talia Donenberg, Kristen Shannon, Robin C Schwartz, Ellen T Matloff. Conn Med 2010
67
8

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
565
7

Analysis of protein-coding genetic variation in 60,706 humans.
Monkol Lek, Konrad J Karczewski, Eric V Minikel, Kaitlin E Samocha, Eric Banks, Timothy Fennell, Anne H O'Donnell-Luria, James S Ware, Andrew J Hill, Beryl B Cummings,[...]. Nature 2016
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.